Timolol-dorzolamid-bimatoprost Coupons & Savings Card – Discount Prices from $61.97
My prescription
Edit
5ML of 0.5-2-0.01%, Timolol-dorzolamid-bimatoprost (1 Bottle)
Select pharmacy
CVS
$94.75
COUPON PRICE
Walmart
$61.97
COUPON PRICE
Walgreens
$72.96
COUPON PRICETimolol-dorzolamid-bimatoprost savings card
Show this card to your pharmacistWalmart
$61.97
BIN
ID
PCN
GRP
019876
LH10C92275
CHIPPO
LHX
Powered by
Timolol-dorzolamid-bimatoprost dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 5ML of 0.5-2-0.01% | 1 Bottle | $61.97 | $61.97 |
Can you take bimatoprost and dorzolamide together?
Yes, bimatoprost and dorzolamide can be used together. They are often prescribed in combination to manage intraocular pressure in conditions like glaucoma. However, it is important for the patient to follow the prescribing doctor's instructions and report any unusual side effects.
Why is there a shortage of dorzolamide-timolol?
The shortage of dorzolamide-timolol may be due to several factors, including manufacturing delays, supply chain disruptions, increased demand, or regulatory issues. It is advisable for patients to consult with their healthcare provider for alternatives or updates on availability.
What drugs interact with dorzolamide?
Dorzolamide may interact with certain medications. It is important to be cautious when using it with other carbonic anhydrase inhibitors, as this can increase the risk of systemic side effects. Additionally, there may be interactions with high-dose salicylates, such as aspirin, which can enhance the effects of dorzolamide. Patients should always inform their healthcare provider of all medications they are taking to avoid potential interactions.
Is bimatoprost the same as Lumigan eye drops?
Yes, bimatoprost is the active ingredient in Lumigan eye drops. Lumigan is a brand name for the medication that contains bimatoprost, which is used to treat certain eye conditions.
Why is there a shortage of glaucoma eye drops?
There is a shortage of glaucoma eye drops due to several factors, including disruptions in the supply chain, manufacturing delays, and increased demand. These issues can be caused by raw material shortages, regulatory challenges, or production capacity limitations. Patients are advised to consult with their healthcare providers for alternative treatments or solutions during such shortages.